ArticleACR open rheumatology2023

Selective Inhibition of the MK2 Pathway: Data From a Phase IIa Randomized Clinical Trial in Rheumatoid Arthritis.

David Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.